Generic drug
Insulin glargine price, strengths & recalls
Generic of Lantus, Basaglar, Semglee, Toujeo, Rezvoglar
Pharmacies pay $43.44 for 15 mL of Insulin glargine 100 units/mL, 3 mL pen this week, and from $43.44 to $161.77 across its 4 priced strengths and forms. 4 manufacturers make it. It is in shortage (being discontinued). It has 3 recalls on record, none ongoing. Its official label last changed on November 17, 2025.
Being discontinuedGeneric- Fair cash price
- $60.46
- Strengths
- 4
- Makers
- 4
- Updated
- Nov 11
Insulin glargine price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 100 units/mL injection | $6.09 | $60.87 / 10 mL | ||
| 100 units/mL, 3 mL pen | $2.90 | $43.44 / 15 mL | ||
| 100 units/mL, 3 mL pen | Not priced this week | |||
| 300 units/mL, 1.5 mL pen | $26.99 | $121.44 / 4.5 mL | ||
| 300 units/mL, 3 mL pen | $26.96 | $161.77 / 6 mL | ||
Brand names of insulin glargine
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
Shortages
- Rezvoglar, Injection, 100 [iU]/1 mL (NDC 0002-8980-05)A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday...
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Insulin glargine
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use INSULIN GLARGINE-YFGN safely and effectively. See full prescribing information for INSULIN GLARGINE-YFGN.INSULIN GLARGINE-YFGN injection, for subcutaneous useInitial U.S. Approval: 2021Insulin glargine-yfgn is a biosimilar* to LANTUS (insulin glargine).
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- BLA761201 · Mylan Pharms Inc
- First approved
- July 28, 2021 (5 years ago)
- Latest approved change
- November 25, 2024
- Approved label
- PDF, Nov 26, 2024
- Generic makers
- None on the market
Insulin glargine questions
How much does insulin glargine cost without insurance?
Pharmacies pay about $43.44 for 15 mL of insulin glargine 100 units/mL, 3 mL pen ($2.90 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $60.46. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of insulin glargine?
Is insulin glargine in shortage?
Yes. 1 product is listed as in shortage or being discontinued (being discontinued). See which ones.
Has insulin glargine been recalled?
3 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the insulin glargine label last change?
The official label was last updated on November 17, 2025 (version 1). See what changed.
Talk about insulin glargine
No comments yet. Questions, tips, what worked for you - start the conversation.